Antilipidemic effect of nafenoic acid.
D001565:Benzoates / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood*; D009281:Naphthalenes / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use*; D014280:Triglycerides / Q000037:antagonists & inhibitors* / Q000097:blood
D001565:Benzoates; D000960:Hypolipidemic Agents; D008055:Lipids; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol